🔗 Share this article

Chancellor Reeves has stated she is preparing "focused steps to address cost of living issues" in the forthcoming financial statement.

During an interview with the BBC, she noted that curbing inflation is a joint duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this year and next.

Possible Utility Cost Interventions

It is understood the administration could intervene to bring down utility costs, for instance by cutting the current 5% rate of value-added tax charged on energy.

An additional possibility is to cut some of the government charges presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The government will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such measures.

The expectation from most experts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to meet her self-imposed fiscal targets.

Earlier on the same day, calculations indicated there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a collective task between the Bank of England and the government to continue tackling some of the drivers of price increases," Reeves stated to reporters in Washington, at the conferences of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on likely tax increases, the chancellor said the latest figures from the OBR had not altered her pledge to election pledges not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial concerns for the Budget tax moves, probably to be targeted on those "with the broadest shoulders."

Global Trade Disputes

Addressing apprehensions about the UK's commercial links with China she said: "Our security interests invariably are paramount."

Last week's declaration by Chinese authorities to increase export controls on critical minerals and other materials that are essential for high-technology manufacturing led US President Donald Trump to suggest an additional 100% tariff on imports from China, increasing the possibility of an full-scale trade war between the two largest economies.

The American finance chief labeled China's move "commercial pressure" and "a global supply chain control attempt."

Asked about considering the US offer to join its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese actions and urged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and causes further headwinds."

"In my view there are areas where we should confront Chinese policies, but there are also important prospects to sell into China's economy, including banking sector and other areas of the economic system. We've got to maintain that balance appropriate."

The Treasury chief also stated she was collaborating with G7 counterparts "on our own essential resources strategy, so that we are reduced dependence."

NHS Medicine Pricing and Investment

Reeves also recognized that the price the National Health Service pays for medicines could increase as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

A number of the world's largest drug companies have said recently that they are either delaying or canceling investments in the United Kingdom, with several blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the price the NHS pays for medicines would need to rise to stop businesses and pharmaceutical investment departing from the UK.

Reeves told media: "It has been observed due to the payment system, that clinical trials, innovative medicines have not been offered in the UK in the way that they are in other EU nations."

"We want to guarantee that individuals receiving treatment from the NHS are able to receive the finest life-saving medicines in the globe. And so we are looking at these issues, and... aiming to obtain more capital into Britain."